Antiphospholipid Syndrome
74
22
22
24
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.1%
3 terminated out of 74 trials
88.9%
+2.4% vs benchmark
15%
11 trials in Phase 3/4
13%
3 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (74)
Point of Care Testing INR in Antiphospholipid Syndrome
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Pregnancy and Medically Assisted Conception in Rare Diseases
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Rheumatology Patient Registry and Biorepository
Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)
Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome
The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome